ArticleDisease models & mechanisms2012

Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.

Juan Manuel Decara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.